Peter Truesdell
Kingston, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes.
Journal: NPJ precision oncology
Published: February 27, 2024
Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models.
Journal: Oncoimmunology
Published: June 11, 2018
MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinoma.
Journal: Cellular signalling
Published: February 07, 2018
Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers.
Journal: Breast cancer research : BCR
Published: March 24, 2017
CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer.
Journal: Gynecologic oncology
Published: January 03, 2017
A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer models.
Journal: Oncotarget
Published: November 04, 2016
Endophilin A2 Promotes TNBC Cell Invasion and Tumor Metastasis.
Journal: Molecular cancer research : MCR
Published: October 22, 2014
Toca-1 is suppressed by p53 to limit breast cancer cell invasion and tumor metastasis.
Journal: Breast cancer research : BCR
Published: March 06, 2014
CIP4 promotes lung adenocarcinoma metastasis and is associated with poor prognosis.
Journal: Oncogene
Published: August 30, 2013
Fer protein-tyrosine kinase promotes lung adenocarcinoma cell invasion and tumor metastasis.
Journal: Molecular cancer research : MCR
Published: May 24, 2013
Last Updated: 09/26/2026